AT Impf 100 Beteiligungs GmbH
Foundation
Key facts about this entity
Entity type: Special-purpose investment holding vehicle
Schema.org type: Organization
Country: Germany
Ownership: Strüngmann family-office structure
Parent organization: Santo Holding GmbH (Zug, Switzerland)
Founder: Andreas Strüngmann; Thomas Strüngmann
Sector: Family-office investment holding; biotechnology
Associated organization: BioNTech SE; Athos KG
Entity Profile
Overview
AT Impf 100 Beteiligungs GmbH is a German-domiciled special-purpose investment vehicle within the Strüngmann family-office structure. It is parented by Santo Holding GmbH in Zug, Switzerland. Despite the Foundation classification carried in some internal ledgers, its operating function is that of a holding company rather than a philanthropic foundation.
Why this entity matters
AT Impf 100 Beteiligungs GmbH is the specific legal vehicle through which the founding BioNTech SE position is held. As such it is one of the most consequential single investment vehicles in European biotech history and a defining case in DACH family-office structuring for anchor life-sciences positions.
Career, company or institutional background
The vehicle deployed the approximately €150M (source range €136.5M to €180M) seed capital provided by Andreas and Thomas Strüngmann to BioNTech SE at its 2008 founding in Mainz — one of the largest seed rounds in European biotech history.
Role in the startup, technology, investment or innovation ecosystem
AT Impf 100 Beteiligungs GmbH held the single largest external shareholder position in BioNTech SE from founding through the 10 October 2019 Nasdaq IPO and the August 2021 pandemic-era peak, when the AT Impf-mediated joint Strüngmann stake was valued at more than USD 50B. Following partial secondary sales in November 2023 (approximately USD 110M sold plus USD 220M planned), the joint stake was reported at approximately 43.5 percent in late 2023 — remaining the largest and most influential shareholder position in the company.
Selected relationships and affiliations
Santo Holding GmbH in Zug (parent organisation); Andreas Strüngmann and Thomas Strüngmann (ultimate owners); BioNTech SE (portfolio company); Athos KG (associated Strüngmann family-office vehicle).
Startuprad.io relevance
The vehicle is a persistent reference in Startuprad.io's coverage of the BioNTech shareholder architecture and of DACH family-office structuring for anchor biotech positions.
Public source context
Public references are limited to the shareholder-structure disclosures around BioNTech SE and the joint Strüngmann Wikipedia and Wikidata entries.